Educated healthcare providers on the benefits of Paxlovid the antiviral treatment for COVID-19 during Emergency Use Authorization prior to its launch in 06/2023. Also promoted Prevnar 20 (adult pneumococcal vaccine) and Bivalent/Pfizer-BioNTech COVID-19 Vaccine (currently under EUA). Call points included family practice, internal medicine, surgeons, and all types of specialty physicians in a region encompassing Sugar Land, Missouri City, Richmond, Rosenberg, Lake Jackson, and the surrounding area. ✔Successfully launched Paxlovid in 06/2023 upon FDA approval. Pre-launch activities included successfully completing Paxlovid certification and developing a strategic routing plan to call on appropriate targets.✔Achieved incentive compensation reach and frequency goal obtainment of 100% on targeted HCPs (goal was 80%). ✔Served as a peer educator for new hires and presented sales data on conference calls to help counterparts develop business plans. ✔Averaged 13 HCP calls per day, ranked #1 in the District and Top 5% in the Region.✔Obtained other product certifications for Prevnar 20 and Bivalent.

Relaunched the first and only FDA approved oral testosterone replacement therapy, JATENZO. Called on Houston Medical Center KOLs within specialty fields of Urology and Endocrinology, as well as Internal Medicine and Family Practice in the greater Houston area. ✔Called on specialty pharmacies and scheduled value-added in-services all of which resulted in an increase in MS and NRx. ✔Attained a 96% increase quarter-over-quarter in NRx. ✔Ranked #2 nationally for NRx growth.✔Achieved 168.62% of target Q2 FY2022.✔Ranked #11th overall out of 60 representatives.

Part of the team to launch the Phase III seasonal launch of single-dose antiviral Xofluza for Genentech in the Southwest Houston Territory. Call points included Urgent Care, Freestanding ERs, Pediatric, and Primary Care offices. ✔Exceeded individual MS goal for the territory attaining 15.4% (goal was 14.5%). ✔Led the district in pharmacy calls per day with a 9.2 call average per day (called on 94% of targeted HCPs).✔Sampled 83% of targeted HCPs.✔Attained 111% market share Q3 FY2021.✔Ranked #1 for a one week pharmacy call contest and attained 1st place ranking for a district sampling contest.✔Selected by District Manager to work vacant territories.✔Appointed to be a Peer Mentor/Trainer for new hires. Conducted ride a-longs, tutored CVAs to prepare for certification and provided constructive feedback.

Marketed and promoted multiple products to Primary Care Physicians, Internal Medicine, Pulmonologists, and Allergists in the Houston market. Identified and developed thought leaders and delivered high quality, value-added programs. Responsible for 150 healthcare providers and a marketing budget of $20k.Leadership Engagement▬▬▬▬▬▬▬▬▬▬✔Executed successful routings and sales plans to generate increased sales for the launch of Breo, Anoro, Trelegy, Incruse, and Arnuity.✔Promoted products such as Incruse, Arnuity, Anoro, Breo, Trelegy, and Advair.✔Partnered on sales calls with Hospital Reps to grow business and gain formulary access with P&T physicians. ✔Inclusion and Diversity Champion. Trained representatives to create a GSK culture where everyone feels valued, respected and empowered. ✔Recognized by the Regional VP of Sales for exceptional technical product knowledge, business acumen, and customer engagement. ✔Regional Technology Liaison on GSK 360 “Capturing Account Imperfections.” ✔Regional Advisory Task Force and Training Mentor, 2013.Select Accomplishments▬▬▬▬▬▬▬▬▬▬✔Q3 2019 West Sector Ranking #15/252 for NBRx. Share Change of 3.1%.✔Q3 2019 West Sector Ranking #60/252 for NBRx. Share of 17.7%.✔Q3 2019 #3 ranking out of 37 for Regional Market Share Change of 3.1%.✔Q2 2019 #2 ranking out of 37 for Regional Market Share of 14.5%. Recognized at National Meeting in Orlando.✔Q2 2019 #2 ranking out of 37 for Regional Market Share Change of 3.7%. ✔Q1 2019 #1 ranking out of 37 for Regional Market Share Change for Pulmonologists of 7.8%.✔Q1 2019 #3 ranking out of 37 for Regional Market Share Change of 2.9%.✔2018 Silver Certificate for Achieving Top and Bottom Line Plan three consecutive years. ✔2018 Silver Certificate for Top 20% in the Nation.✔2017 and 2014 Bronze Certificate for Top Share Growth in the Region.✔2014 Patient First Share Award for Contribution to Regional Sales Success.✔2013 Patient First Share Award for Top 10% in the Nation.

Responsible for marketing Advair and Veramyst to Primary Care Physicians, Internal Medicine, Pulmonologists, Allergists, and Pediatricians in the greater Houston market. ✔Winner’s Circle Silver Award Recipient, ranked in the top 10%, 2010.✔Winner’s Circle Ruby Award Recipient, ranked in the top 20%, 2007.✔Developed and executed successful routings and sales plans to generate increased sales for the launch of Veramyst.✔Exceeded territory sales by increasing new prescribers, executing planned territory strategies, conducting tailored total office calls, pulling-through managed care initiatives, and conducting successful in-services/dinner programs. ✔Functioned as a primary product contact for clients. Nurtured client relationships and utilized customer-focused sales techniques to open new business lines. ✔Selected as a Payer Market Liaison accounting for ensuring district-level, provider-centered, pull-through via payer acumen and communication of changes in formularies to all sales representatives.✔Member of Regional Advisory Task Force and Training Mentor, 2012.

Marketed and promoted multiple products to Family Practice, Internal Medicine, Pulmonologists, Allergists, Psychiatrists, and Pediatricians in the greater Houston region.✔Promoted products including Wellbutrin, Wellbutrin XL (Zyban), Flonase, Flovent, Serevent, Ceftin, Advair, and Raxar✔Developed and executed successful routings and sales plans to generate increased sales for the launch of Advair and Raxar.✔Winner’s Circle Ruby Award Recipient, ranked in the top 20%, 2006.✔Completed a Sales Professional Preceptorship at the National Jewish Hospital under Dr. Harold Nelson M.D.✔Served as a member of The National Convention Team.